|
|
Welcome to the January edition of the OBN Monthly Newsletter.
|
|
|
|
Grey Wolf completes £2.5m Series A2 financing for development of therapies targeting ERAP2
|
Grey Wolf Therapeutics
, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology (IO), this month announced it has completed a £2.5 million Series A2 financing round with existing leading international healthcare investors Andera Partners and Canaan.
The new funding – all from existing investors – will allow the company to accelerate development of therapies targeting endoplasmic reticulum aminopeptidase 2 (ERAP2), following many positive signals of its potential. Funds will also be used to continue to drive the lead endoplasmic reticulum aminopeptidase 1 (ERAP1) modulator program.
|
|
Celebrating the Success of
BioSeed® 2020
BioSeed 2020
, which was sold out months in advance, was a huge success, and included a packed schedule of quickfire 5-minute presentations from 46 early stage life sciences companies, who showcased a range of new technologies and treatments in front of an attentive audience of over 100 investors. During the afternoon there was over 300 partnering meetings, an Investor Q&A session and a vibrant evening drinks reception.
John Harris
, CEO of OBN said,
“
The quality, breadth, and innovative nature of the company presentations (from across Europe) was highly impressive, pitched to an extensive, relevant and high-quality investor audience. An intense but fascinating day!
Undoubtedly, BioSeed is now established as the premier UK-based event for early stage funding, genuinely meeting the needs of companies seeking growth capital and investors seeking access to exciting new investable opportunities."
If you missed out this time, we will be running
BioSeed
in 2021 so please keep an eye on
www.bioseed.co.uk
for details.
|
|
Book today and save £200!
Just a quick reminder that the Early Bird Rate for BioTrinity 2020 finishes at 5pm TODAY, 31 January; so if you are keen to attend, click
here
to register. Full delegate tickets currently cost £700 plus VAT for OBN members and £1,000 plus VAT for non-members, with rates rising by £200 after the deadline.
BioTrinity
, OBN's flagship conference takes place in London from
28-29 April
, has a focus on partnering, investment, collaboration and networking for companies throughout the life sciences industry at all stages of development.
So, if you are looking to raise your company profile to a targeted and engaged audience of early-stage and emerging biotech, medtech and digital health companies, big pharma and life sciences investors then book your BioTrinity ticket
here
.
|
|
Calling all Oncology Participants
Going to BIO in the US? Fancy having a
FREE
opportunity to promote and showcase your oncology technology to a large international audience?
As always, OBN will be heavily involved as a primary partner and is offering the opportunity for
five UK ground-breaking oncology-based early stage companies
to participate. There are three presentation and two poster slots available for the event, and we are looking for new and innovative companies with the passion and ambition to demonstrate their interest and novel approach to products and/or technology within the oncology space.
f you would like to be considered to join the OBN / UK delegation, please email a short (no more than half page of A4) profile of your company and technology to Rebecca Wilkes,
[email protected]
, by
February 28th
at the latest.
|
|
Working with VABeachBio in 2020
We are delighted to announce that
VABeachBio
will be continuing to support OBN as a Corporate Sponsor for 2020 and also coming on board as an Event Supporter of BioTrinity 2020.
VABeachBio
is a destination for ground-breaking research and development, and headquarters of some of the world's leading innovators in healthcare, biotechnology and healthcare delivery systems. Virginia Beach is strategically located on the East Coast of the United States in the ‘Bio Health Capital Region’, right in between two major bio hubs - the Raleigh Durham Research Triangle and Washington D.C.
Taylor Adams, Director at Virginia Beach Economic Development, said: “
We are delighted to be working with OBN again this year and are looking forward to meeting members and contacts from the UK life sciences industry – we’ll be present at many events this year, including BioTrinity in London in April. We hope to build positive relationships and ultimately offer support and advice to organisations who may be thinking about relocating to (suggest ‘locating in’) the US, and in particular shine a light on the fantastic offering we have at here at Virginia Beach
”
We would like to thank
VABeachBio
for their continued support and look forward to working with them in 2020.
|
|
Who is in the OBN Spotlight this month....
Sarah Walker, our Senior Events Manager, has kindly shared her story with us this month...."I’ve been at OBN for just over three years now, before joining OBN I worked for Innovate UK within their events team for almost 7 years.
At OBN I look after BioLearn – OBN’s growing portfolio of training courses. I also help to organise the annual BioSeed event – I love working with companies and helping them through their funding journey! You will also see me at our regular BioTuesday and SEBC events.
My spare time is mostly spent underwater! Preferably in warmer climes but also wreck diving on the UK Coast or in the extremely chilly UK quarries. If I am not diving, I’m exploring off exploring the UK with my partner in our camper with our two 5-year old rescue Bichons, Mushy and JJ (we didn’t name them!)".
|
|
Welcome to our new Members:
|
|
Improving outcomes for patients on dialysis, and other extra-corporeal treatments
|
|
Offers a range of best-in-class kits and reagents for PCR and related technology
|
|
Developed the Diabrid Platform Technology proprietary for the high level expression of biosimilars in specially designed genetically stable clones
|
|
A drug discovery Contract Research Organization that offers medicinal chemistry and computational chemistry services
|
|
International scientific laboratory and consultancy business that offers a range of services in life, food, and environmental sciences
|
|
One of the South West's largest independent insurance brokers
|
|
Provide drug discovery expertise and capabilities to pharmaceutical and biotechnology companies as well as to academic institutions
|
|
A business consultancy firm providing services to life science companies
|
|
A global leader for science and enterprise with world class laboratories and exceptional office space
|
|
A management consultancy offering new approaches to support the development and commercialization of advanced science and technologies
|
|
Bring hair rejuvenation and regeneration into routine clinical practice and make hair loss a thing of the past
|
|
Help and advises foreign companies in all phases of establishing, rolling out and/or expanding their international activities in the Netherlands
[
|
|
|
|
Developed a pipeline to design and rapidly generate focused libraries of molecules that can hit previously undruggable targets
[
|
|
A proteomic-data science and diagnostics company specialising in cell signalling
|
|
Through our Alliance partnership with
BioPartner UK
OBN Members are eligible for significant registration discounts on a wide range of other conferences.
Take a look at all the other events which you would be eligible to for a discount on by visiting
www.biopartner.co.uk/events
and look for all of those who have the icon above.
|
|
Contact
Lee Pratley
to find out how you can make huge savings on Lab and office supplies, business travel, utility bills and our new Purchasing Platform.
|
|
Centre for Functional Genomics Launch Event
Tuesday 4 February at 18:00 in the JHB Lecture Theatre
Oxford Brookes University
Event programme:
18:00
Dr. Saad Arif (Centre for Functional Genomics Scientific Director): “Research and Teaching Functional Genomics at Oxford Brookes University”.
18:15
Dr. Dianne Newbury (Reader in Medical Genetics and Genomics, Oxford Brookes University):
Investigating the Genomics of Speech and Language”.
18:45
Professor Matthew Loose (Director of Deep Seq, University of Nottingham): “Nanopore Sequencing from Large Genomes to Small Regions”.
19:15
Drinks and nibbles.
|
|
Concept Life Sciences GMP Launch Event
Manufacturing & Development
Wednesday 26 February
Discovery Park
This science focused event will bring together experts from across the drug discovery & development landscape; sharing their knowledge and experiences from Process R&D and manufacturing through to pharmaceutical development
For more information and to book please click
here
|
|
Scottish Life Sciences The Summit 2020
Thursday 27 February 2020, 09:30 - 17:00
King’s College Conference Centre
For more information about the event and how to register please click
here
|
|
Join Us!
If you have any News, Jobs or Events you would like to share with OBN Members and Contacts, please email
Rebecca Wilkes
, Communications and Marketing Coordinator, with the details
.
|
|
Thank you to all our OBN Sponsors
|
|
|
|
|
|
|
